NotíciasUniQure's Embattled Huntington's Gene Therapy Clears A Key Hurdle
Uniqure stock wavered Wednesday after the Food and Drug Administration accepted its application for approval of a Huntington's gene therapy.
The post UniQure's Embattled Huntington's Gene Therapy Clears A Key Hurdle appeared first on Investor's Business Daily.
